Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    

HOSPIRA, INC.
Mes dernières consult.
Most popular
Report
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensus 
Company
Hospira, Inc. provides injectable drugs and infusion technologies.Its offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services.The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.  
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on HOSPIRA, INC.
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
2015 PFIZER : Buy of Hospira Gets Green Light
2015 PFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
2015 HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
2015 HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
2015 HOSPIRA : TGA Approves First mAb Biosimilar
2015 HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
2015 PFIZER : Gets EU Green Light for Hospira Merger
2015 HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
More news
Sector news : Generic Pharmaceuticals
08:22p Canada's small financial firms get buzz from weed stocks
07:59p Big Drugmakers Pay Big Prices for Promising Biotechs
07:11p Wall St. at session highs on deal to end U.S. shutdown
06:16p Dealmaking drives European stocks as equity melt-up continues
06:14p UK stocks decline as gamblers stumble on government clampdown worries
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
HOSPIRA, INC. - 2013
End of the technical recovery
SELL
More Strategies
News from SeekingAlpha
2017 Upcoming Events - Panel For Epogen Biosimilar And Ocaliva's Lipid Test For Na..
2016 ABBOTT : Current Uncertainties Offer A Buying Opportunity
2016 New Management At ICU Medical Has Produced Positive Results
2016 PFIZER : 30%+ Discount With 4% Yield
2015 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
Income Statement Evolution
Managers
NameTitle
John D. Young President
Zena G. Kaufman Senior Vice President-Quality
Paul Greenland Vice President-Biologics
Sector and Competitors